Clinical Evidence for Therapeutic Effects and Safety of Animal Venoms
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Animal Venoms".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 90
Special Issue Editors
Interests: venom; drug discovery; pharmacology; herbal medicine; immune response
Special Issues, Collections and Topics in MDPI journals
Interests: animal venom; bee venom, herbal medicines; pharmacopuncture (herbal acupuncture); pain
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bee venom therapy is used to treat musculoskeletal diseases (e.g., low back pain, knee osteoarthritis), Parkinson’s disease, adhesive capsulitis, and polycystic ovary syndrome; snake venom-based drugs are used to treat hypertension, heart attack, acute coronary syndrome, stroke, pulmonary embolism, and other diseases; scorpion venom has strong anti-inflammatory, antibacterial, and anticancer effects. New species of venomous animals are being discovered, requiring the establishing of the venom profiles and molecular mechanisms of venom action. Thus, in order to apply animal toxins to disease treatment, the establishment of clinical evidence and the verification of safety are required. However, recent basic/clinical knowledge has been lacking in the diverse clinical use of animal venoms, despite many off-label uses for them.
Thus, this Toxins Special Issue is devoted to understanding basic knowledge and clinical evidence for therapeutic effects and the safety of animal venoms for treating various diseases.
Dr. Gihyun Lee
Dr. Soo-Hyun Sung
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- animal venom
- snail venom
- spider venom
- scorpion venom
- snake venom
- bee venom
- clinical study
- systematic review
- clinical practice guidelines (CPG)
- therapeutic effects and its mechanism
- safety and adverse events
